The role of IL-5 in severe asthma

Watch Dr Hitasha Rupani, Consultant Respiratory Physician at University Hospital Southampton, discuss the role of IL-5 in type 2 inflammation, highlighting the interconnected mechanisms driving airway inflammation and the resulting clinical signs and disease burden.
Disclosures
Grants/research support (to Dr Rupani's institution) from AstraZeneca and GSK. Speaker's bureau/honoraria and advisory boards supported by Advanz Pharma, Areteia Therapeutics, AstraZeneca, GSK and Sanofi. Conference support from AstraZeneca and Sanofi.
NX-GB-ASU-VID-250002 | January 2026